Pando Group is comprised of highly professional individuals each bringing with them their own unique experience and skill set to form a well-rounded team dedicated to the growth and ultimate success of its portfolio companies. This invaluable composition enables Pando Group to help Israeli companies bridge the gap that would otherwise pose an obstacle to them in the Asian market.
Mrs. Yan Zhao - Chairwoman
Over the past two decades Mrs. Zhao has become a force to be reckoned with in the fields of real estate development and operations, biotechnology, pharmaceuticals and equity investment.
Mrs. Zhao, is the majority shareholder in, and serves as Chairman and Executive Director of, Bloomage BioTechnology Corporation Limited, an investment holding company (traded on the Hong Kong stock exchange) that, through its various subsidiaries, develops, manufactures, and sells bio-chemical products, in particular, the production and sale of hyaluronic acid raw materials used in pharmaceutical, cosmetic, and food products in the People’s Republic of China (PRC).
Bloomage Empery Beauty Holdings Ltd., a subsidiary of Bloomage BioTechnology Corporation Limited, holds 80% of Pando Groups share capital. Indeed, Mrs. Zhao holds board positions in all of the company’s subsidiaries including, among others, Bloomage Freda Biopharm Co., Ltd. (USA) (Formerly Shandong Freda Biopharm Co., Ltd.), a company established in 1998 by Bloomage International Investment Group Inc. and Shandong Freda Pharmaceutical Group Corporation which, over the past 20 years has focused its efforts on R&D, production and sales of Sodium Hyaluronate.
Between the years 2000 to 2002 Mrs. Zhao served as General Manager of Bloomage Holystar Investment Co. Ltd., a company engaged in the provision of venture capital, investment management and consultancy services and business management consultancy services.
In addition to her other numerous roles Mrs. Zhao currently serves as Chairman and General Manager of Bloomage International Investments Group Inc. (formerly known as Bloomage Investments Co., Ltd), an investment holding company the subsidiaries of which are principally engaged in property development and investments as well as the operation and management of stadiums and commercial projects, all within the PRC. Mrs. Zhao is primarily responsible for the companies’ corporate policy formulation, business strategic planning and business development. Mrs. Zhao holds a B.Sc in biology from East China University and an MBA from Fordham University, in the United States.
Mr. Xuekun Jin - Managing Partner
Mr. Xuekun brings with him over 20 years of experience in the medical industry, in particular, the sale and marketing of medical instruments.
Aside from being a Managing Partner in Pando Group Mr. Xuekun currently serves as Chief Executive Officer and Executive Director of Bloomage BioTechnology Corporation Limited, an investment holding company (traded on the Hong Kong stock exchange - MKT Cap 6.7 Billion HKD) that, through its various subsidiaries, develops, manufactures, and sells bio-chemical products, in particular, the production and sale of hyaluronic acid raw materials used in pharmaceutical, cosmetic, and food products in the People’s Republic of China (PRC).
Prior thereto Mr. Xuekun served as General Manager of Esaote (Shenzhen) Medical Equipment Co., Ltd., part of the Esaote Group (Italy), which is ranked among the worlds leading producers of medical diagnostic systems and digitalized medical imaging products and services as well as being a key player in the healthcare information technology sector. Mr. Xuekun also served as Vice President of Chindex (Beijing) International Trade Company Limited from 2001 to 2006 during which time he was responsible for marketing medical imaging equipment in the PRC. Earlier on in his career Mr. Xuekun was employed by the China Rehabilitation Research Center where he was responsible for medical imaging.
In 2002 Mr. Xuekun was awarded a masters degree of business administration by Fordham University, in the United States.
Mr. Ron-Edoute Oded - General Partner
Mr. Ron-Edoute has accumulated over 25 years of experience in sales and, marketing with a proven senior management track record. Needless to say, Mr. Ron-Edoute possesses extensive networking skills coupled with the requisite expertise and knowledge necessary for setting up international structures and joint ventures from the early stages of startup all the way to an IPO.
Prior to establishing Pando Group, Mr. Ron-Edoute co-founded and served as Chairman, at Venus Concept Ltd., a fast growing company at the forefront of innovative medical aesthetic technologies. He also served as Vice President of International Sales at Syneron (NASDAQ-ELOS) where he developed the global markets from scratch with particular emphasis on Asia and specifically in China. Prior to his tenure at Syneron Mr. Ron-Edoute served as President of Radiancy Inc. (NASDAQ-PHMD), Europe and Asia, during which time the company, under his skillful management, launched one of the most successful home use products for hair removal (“NoNo”).
Mr. Ron-Edoute holds an MBA from Tel Aviv University, Israel and the Heriot Watt University, Edinburgh, UK.
Mrs. Fishgold Orit - General Partner
Mrs. Fishgold possesses more than a decade of top-level managerial experience in the medical and medical aesthetics industries. During such time Mrs. Ron-Edoute, among other things, has accumulated valuable experience in making and retaining business relations with industry giants, including the establishment of joint ventures and strategic partnerships, as well as devising and implementing marketing strategies from start to finish.
Prior to establishing Pando Group, Mrs. Fishgold co-founded and served as the CEO at Venus Concept Ltd., a fast growing company at the forefront of innovative medical aesthetic technologies. Prior thereto she has held several managerial positions in leading bio-medical companies; Mrs. Fishgold served as Vice President of Business Development at Frutarom Industries Ltd., a global scale public company (traded on the Tel Aviv and London stock exchanges) specializing in developing, manufacturing and marketing solutions for key players in the pharmaceutical and cosmetic industries. She also served as Director of Business Development at Proteologics Ltd., a publicly traded biopharmaceutical company specializing in drug discovery.
Mrs. Fishgold holds a B.Sc in Chemistry from Tel Aviv University, Israel and an MBA, majoring in marketing, from Ben Gurion University, Israel.